We then used a publicly available gene expression dataset for primary breast tumors as well as matched NAT 1, 2, 3, and 4 cm away, to determine if enrichment of the lipolysis signature occurred in NAT in comparison to non-tumor breast tissue obtained from healthy individuals using single-set gene set enrichment analysis20,21. The gene discussed is BRD2; the disease is breast neoplasm.